Johnson & Johnson (JNJ)
$144.56 0.24 (0.17%)
15:35 EDT JNJ Stock Quote Delayed 30 Minutes
Previous Close -
Market Cap 387.73B
PE Ratio 314.26
Volume (Avg. Vol.) 3.10M
Day's Range 144.12 - 145.75
52-Week Range 109.16 - 157.00
Dividend & Yield 3.48 (2.41%)
JNJ Stock Predictions, Articles, and Johnson & Johnson News
- From InvestorPlace
- From the Web
While coronavirus numbers start to subside again, many investors are in a pandemic mentality, making these the stocks to buy this week.
JNJ stock is taking a hit on Tuesday after the company announced a pause in its COVID-19 vaccine trial, despite strong Q3 earnings results.
By Joel Baglole
Investors are banking on an upsurge in pharmaceutical stocks once various vaccines and other therapies gain commercial approval from the U.S. Food and Drug Administration (FDA). Here is a list of pharmaceutical companies that stand to benefit in the coming months.
By Alex Sirois
Blue-chip stocks should look especially attractive to investors now that uncertainty reigns. Read on to learn which are strongest.
Because of the unprecedented Covid-19 crisis, many discounted securities appear to be value stocks. Here are seven names that truly deserve that designation.
With the presidential race scorching in tension, the narrative for hot stocks to consider has gotten much more intriguing.
With the shutdowns and uncertainty, millions of Americans have stayed home and played the stock market. But you should also spare some time to consider the best 401k investments.
Chewy, Johnson & Johnson, Slack and Nike were our top stock trades for Thursday. That said, let's look at the charts and find the trade.
JNJ stock is popping Wednesday thanks to news Johnson & Johnson is entering late-stage trials for its coronavirus vaccine.
Buying and holding long-term stocks is not as popular as zero commission trading in 2020, but it remains the best way to make money in the market.
By Alex Sirois
Juicy dividends or explosive growth stocks? Most investors don't want to choose. Here are 6 dividend stocks to keep both sides happy.
By Thomas Niel
Whether or not we get an 'October Surprise' from President Donald Trump, these coronavirus vaccine stocks look hot now. AstraZeneca (NYSE:AZN) CureVac (NASDAQ:CVAC) GlaxoSmithKline (NYSE:GSK) Inovio (NASDAQ:INO) Johnson & Johnson (NYSE:JNJ) Moderna (NASDAQ:MRNA) Novavax (NASDAQ:NVAX)
The healthcare industry has historically delivered market-beating returns. And the current pandemic has created new opportunities in the sector.
Let’s face it – blue-chip stocks aren’t the most popular investments in the new normal. But look a little deeper and you’ll find a stalwart that will suit multiple investment strategies.
With a 20-year timeline, you have multiple choices for dividend stocks to buy. Here are 30 names that should do very well.
You can count on these 20 stocks to buy if you’re betting on America in the long term. Here's why each will stand the test of time.
With an upcoming election and ongoing fiscal stimulus concerns, it is time to get defensive. Here are seven safe stocks to buy now.
Momenta Pharmaceuticals (MNTA) news for Wednesday includes a deal with Johnson & Johnson (JNJ) sending MNTA stock rocketing higher.
Alopecia Market Growth Analysis by Leading Key Players- Johnson & Johnson Services Inc., Cirrus Hair Centers, Cipla Inc., Follica Inc
From Talk Markets
Navellier RatingsPowered by Portfolio Grader